Loading…
Bone Marrow Failure Disease Research and Treatment Act of 2008
Legislative Progress
Introduced
September 11, 2008
Latest Action
September 11, 2008
Primary Sponsor
Doris O. MatsuiDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2009 · second_quarter · Medicare/Medicaid
HR 6331 Medicare Improvements for Patients and Providers Act of 2008, implementation of the Medicare Part D Program; S 3101 Medicare Improvements or Patients and Providers Act of 2008; Part D, Electronic Prescribing, Medicaid Pharmacy Reimbursement. S 3118, Preserving Access to Medicare Act of 2008. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues; HR 758, Price Disclosure Regarding Treatment of Breast Cancer; S 3330 The Medicare Prescription Drug Savings and Choice Act 2009:HR 5605, Physician Payments Sunshine Act of 2008: transparency issues; HR 6884, Medicare Prescription Drug Cost Equalization Act: Part D issues; S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues; S 2029, Physician Payments Sunshine Act of 2007: transparency issues; S 2041, False Claims Act Correction Act of 2007: liability issues; S 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues; S 3396, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing; S 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Medicare/Medicaid
H.R. 1 The American Recovery & Reinvestment Act of 2009: Comparative Effectiveness; HR 6331 Medicare Improvements for Patients and Providers Act of 2008, implementation of the Medicare Part D Program; HR 3162 Children's Health and Medicare Protection Act of 2007; S 3101 Medicare Improvements or Patients and Providers Act of 2008; Part D, Electronic Prescribing, Medicaid Pharmacy Reimbursement. S 3118, Preserving Access to Medicare Act of 2008. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues; HR 758, Price Disclosure Regarding Treatment of Breast Cancer; S 3330 The Medicare Prescription Drug Savings and Choice Act 2009:HR 5605, Physician Payments Sunshine Act of 2008: transparency issues; HR 6884, Medicare Prescription Drug Cost Equalization Act: Part D issues; S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues; S 2029, Physician Payments Sunshine Act of 2007: transparency issues; S 2041, False Claims Act Correction Act of 2007: liability issues; S 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues; S 3396, The Independent Drug Education and Outreach ACt of 2008: direct to physician marketing; S 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
C.W. Bill Young Cell Transplantation Program National Cord Blood Inventory HR 6884 Bone Marrow Failure Disease Research and Treatment Act of 2008
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Medicare/Medicaid
HR 6331 Medicare Improvements for Patients and Providers Act of 2008, implementation of the Medicare Part D Program; HR 3162 Children's Health and Medicare Protection Act of 2007; S 3101 Medicare Improvements or Patients and Providers Act of 2008; Part D, Electronic Prescribing, Medicaid Pharmacy Reimbursement. S 3118, Preserving Access to Medicare Act of 2008. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues; HR 758, Price Disclosure Regarding Treatment of Breast Cancer: transparency; HR 5605, Physician Payments Sunshine Act of 2008: transparency issues; HR 6884, Medicare Prescription Drug Cost Equalization Act: Part D issues; S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues; S 2029, Physician Payments Sunshine Act of 2007: transparency issues; S 2041, False Claims Act Correction Act of 2007: liability issues; S 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues; S 3396, The Independent Drug Education and Outreach ACt of 2008: direct to physician marketing; S 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
S. 3230, Labor-HHS-Education Appropriations Bill, FY 2009, biomedical research H.R. 2638, (Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, FY 2009), Defense Appropriations Bill, FY 2009, research for bone marrow failure disease H. Con. Res. 81, Bone Marrow Disease Resolution H.R. 6884, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Science/Technology
S. 3230, Labor-HHS-Education Appropriations Bill, FY 2009, biomedical research H.R. 2638, (Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, FY 2009), Defense Appropriations Bill, FY 2009, research for bone marrow failure disease H. Con. Res. 81, Bone Marrow Disease Resolution H.R. 6884, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Medical/Disease Research/Clinical Labs
S. 3230, Labor-HHS-Education Appropriations Bill, FY 2009, biomedical research Medicare coverage of erythropoiesis stimulating agents (ESAs) H.R. 6884, Bone Marrow Failure Disease Research and Treatment Act H.R. 2638, (Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, FY 2009), Defense Appropriations Bill, FY 2009, research for bone marrow failure disease H. Con. Res. 81, Bone Marrow Disease Resolution
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Budget/Appropriations
S. 3230, Labor-HHS-Education Appropriations Bill, FY 2009, biomedical research H.R. 2638, (Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, FY 2009), Defense Appropriations Bill, FY 2009, research for bone marrow failure disease H.R. 6884, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2008 · fourth_quarter · Health Issues
C.W. Bill Young Cell Transplantation Program National Cord Blood Inventory H.R.6884: Bone Marrow Failure Disease Research and Treatment Act of 2008
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
C.W. Bill Young Cell Translantation Program, National Cord Blood Inventory, H.R.6884: Bone Marrow Failure Disease Research and Treatment Act of 2008.
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2008 · third_quarter · Health Issues
C.W. Bill Young Cell Transplantation Program National Cord Blood Inventory H.R.6884: Bone Marrow Failure Disease Research and Treatment Act of 2008
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
| Democratic |
| TN |
| Bob Etheridge | Democratic | NC |
| C. A. Dutch Ruppersberger | Democratic | MD |
| Chris Van Hollen | Democratic | MD |
| Diana DeGette | Democratic | CO |
| Eliot L. Engel | Democratic | NY |
| Fortney Pete Stark | Democratic | CA |
| Frank R. Wolf | Republican | VA |
| Gene Green | Democratic | TX |
| Henry A. Waxman | Democratic | CA |
| James P. McGovern | Democratic | MA |
| James Ramstad | Republican | MN |
| Janice D. Schakowsky | Democratic | IL |
| Jason Altmire | Democratic | PA |
| Jerrold Nadler | Democratic | NY |
| Jim McDermott | Democratic | WA |
| Jo Ann Emerson | Republican | MO |
| John Conyers, Jr. | Democratic | MI |
| John Doolittle | Republican | CA |
| John Lewis | Democratic | GA |
| John McHugh | Republican | NY |
| John Murtha | Democratic | PA |
| Madeleine Z. Bordallo | Democratic | GU |
| Mazie K. Hirono | Democratic | HI |
| Michael Arcuri | Democratic | NY |
| Michael F. Doyle | Democratic | PA |
| Michael M. Honda | Democratic | CA |
| Neil Abercrombie | Democratic | HI |
| Patrick J. Tiberi | Republican | OH |
| Peter T. King | Republican | NY |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Thomas Allen | Democratic | ME |
| Todd Russell Platts | Republican | PA |